First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial
Identificadores
Identificadores
Fecha de publicación
2014Tipo de contenido
Artigo